Ginsenoside-Rd, a purified component from panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice

European Journal of Pharmacology

Volumn 652, Issue 1-3, 2011, Pages 104-110

  Li, Jie ^a,b   Xie, Zhi Zhong ^c   Tang, Yong Bo ^a   Zhou, Jia Guo ^a   Guan, Yong Yuan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

ApoE knockout mice; Atherosclerosis; Ginsenoside Rd; Macrophage; Receptor operated; Store operated; Voltage independent Ca2+ channels

Indexed keywords

APOLIPOPROTEIN E; CALCIUM ION; CHOLESTEROL; FURA 2; GINSENOSIDE RD; GLYCEROL 2 ACETATE 1 OLEATE; LIPID; MANGANESE; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; SCAVENGER RECEPTOR A; THAPSIGARGIN; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ASSAY; FLUOROMETRY; FOAM CELL; IN VITRO STUDY; INTRACELLULAR TRANSPORT; KNOCKOUT MOUSE; LIPID DIET; MOUSE; NONHUMAN; PANAX NOTOGINSENG; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CALCIUM CHANNELS; CELL LINE; CHOLESTEROL; GINSENOSIDES; MACROPHAGES; MICE; MICE, KNOCKOUT; PANAX NOTOGINSENG; SAPONINS; TRIGLYCERIDES;

EID: 78650875275     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.11.017     Document Type: Article

References (34)

1. 2+ entry dependent on TRPC1 Circ. Res. 93 2003 839 847
2. A. Berthier, S. Lemaire-Ewing, C. Prunet, S. Monier, A. Athias, G. Bessede, J.P. Pais de Barros, A. Laubriet, P. Gambert, G. Lizard, and D. Neel Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis Cell Death Differ. 11 2004 897 905
3. S.M. Borcherding, S.G. Meeves, N.E. Klutman, and P.A. Howard Calcium-channel antagonists for prevention of atherosclerosis Ann. Pharmacother. 27 1993 61 67
4. D.K. Bowles, C.L. Heaps, J.R. Turk, K.K. Maddali, and E.M. Price Hypercholesterolemia inhibits L-type calcium current in coronary macro-, not microcirculation J. Appl. Physiol. 96 2004 2240 2248
5. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
6. 2+ entry blocker, reverses basilar hypertrophic remodeling in stroke-prone renovascular hypertensive rats Eur. J. Pharmacol. 606 2009 142 149
7. M.K. Cathcart Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis Arterioscler. Thromb. Vasc. Biol. 24 2004 23 28
8. G.F. Clunn, S. Wijetunge, and A.D. Hughes Effect of hypercholesterolaemia on voltage-operated calcium channel currents in rabbit arterial smooth muscle cells J. Hum. Hypertens. 13 1999 849 853
9. W. Gamble, M. Vaughan, H.S. Kruth, and J. Avigan Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells J. Lipid Res. 19 1978 1068 1070
10. T. Godfraind Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis Philos. Trans. R. Soc. Lond. B Biol. Sci. 360 2005 2259 2272
11. Y.Y. Guan, C.Y. Kwan, H. He, and E.E. Daniel Inhibition of norepinephrine-induced contractile responses of canine mesenteric artery by plant total saponins Blood Vessels 25 1988 312 315
12. 2+ channels in vascular smooth muscle Zhongguo Yao Li Xue Bao 15 1994 392 398
13. 2+ channels in vascular smooth muscle cells Eur. J. Pharmacol. 548 2006 129 136
14. P.D. Henry Atherogenesis, calcium and calcium antagonists Am. J. Cardiol. 66 1990 3I 6I
15. H. Holzgreve, and B. Burkle Anti-atherosclerotic effects of calcium antagonists J. Hypertens. Suppl. 11 1993 S55 S59
16. R. Inoue, L. Hai, and A. Honda Pathophysiological implications of transient receptor potential channels in vascular function Curr. Opin. Nephrol. Hypertens. 17 2008 193 198
17. 2+ entry and respiratory burst: correlations with calcium channel raft trafficking J. Immunol. 178 2007 5253 5261
18. S. Keidar, R. Heinrich, M. Kaplan, T. Hayek, and M. Aviram Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6 Arterioscler. Thromb. Vasc. Biol. 21 2001 1464 1469
19. G. Liu, B. Wang, J. Zhang, H. Jiang, and F. Liu Total panax notoginsenosides prevent atherosclerosis in apolipoprotein E-knockout mice: role of downregulation of CD40 and MMP-9 expression J. Ethnopharmacol. 126 2009 350 354
20. Y. Liu, Y.H. Deng, S.J. Xu, and X. Zeng In vivo pharmaqcolkinetic and metabolism studies of ginsenoside-Rd J. Chromatography B. 854 2007 77 84
21. X. Liu, J. Xia, L. Wang, Y. Song, J. Yang, Y. Yan, H. Ren, and G. Zhao Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial Eur. J. Neurol. 16 2009 569 575
22. Y. Liu, H.G. Zhang, Y. Jia, and X.H. Li Panax notoginseng Saponins Attenuate Atherogenesis Accelerated by Zymosan in Rabbits Biol. Pharm. Bull. 33 2010 1324 1330
23. K.M. Lounsbury, Q. Hu, and R.C. Ziegelstein Calcium signaling and oxidant stress in the vasculature Free Radic. Biol. Med. 28 2000 1362 1369
24. R.P. Mason Atheroprotective effects of long-acting dihydropyridine-type calcium channel blockers: evidence from clinical trials and basic scientific research Cerebrovasc. Dis. 16 Suppl 3 2003 11 17
25. M. Mietus-Snyder, M.S. Gowri, and R.E. Pitas Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation J. Biol. Chem. 275 2000 17661 17670
26. Y. Nagano, H. Arai, and T. Kita High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification Proc. Natl Acad. Sci. USA 88 1991 6457 6461
27. I.V. Smirnova, M. Kajstura, T. Sawamura, and M.S. Goligorsky Asymmetric dimethylarginine upregulates LOX-1 in activated macrophages: role in foam cell formation Am. J. Physiol. Heart Circ. Physiol. 287 2004 H782 H790
28. C.P. Sparrow, S. Parthasarathy, and D. Steinberg Enzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modification J. Lipid Res. 29 1988 745 753
29. Y.B. Tang, Y.J. Liu, J.G. Zhou, G.L. Wang, Q.Y. Qiu, and Y.Y. Guan Silence of ClC-3 chloride channel inhibits cell proliferation and the cell cycle via G/S phase arrest in rat basilar arterial smooth muscle cells Cell Prolif. 41 2008 775 785
30. 2+ handling of smooth muscle cells in aorta of apolipoprotein E-deficient mice before development of atherosclerotic lesions Cell Calcium 41 2007 295 302
31. X. Wang, J. Greilberger, and G. Jurgens Calcium and lipoprotein lipase synergistically enhance the binding and uptake of native and oxidized LDL in mouse peritoneal macrophages Atherosclerosis 150 2000 357 363
32. J.B. Wan, S.M. Lee, J.D. Wang, N. Wang, C.W. He, Y.T. Wang, and J.X. Kang Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion J. Agric. Food Chem. 57 2009 6692 6697
33. S. Yamagishi, K. Nakamura, K. Takenaka, T. Matsui, and H. Inoue Pleiotropic effects of nifedipine on atherosclerosis Curr. Pharm. Des. 12 2006 1543 1547
34. X. Zeng, Y. Deng, Y. Feng, Y. Liu, L. Yang, Y. Huang, J. Sun, W. Liang, and Y. Guan Pharmacokinetics and safety of ginsenoside Rd following a single or multiple intravenous dose in healthy Chinese volunteers J. Clin. Pharmacol. 50 2010 285 292